CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $19.32 ($289,841)
- 4 Open-market sale President & CSO sold 15,000 shares at an average $19.32 ($289,841)
- 4 Open-market sale Chief Dev Operations Officer sold 1,974 shares at $20.00 ($39,480)
- 4 Open-market sale EVP, CBO, GC & Secretary sold 9,660 shares at an average $19.73 ($190,627)
- 4 Open-market sale President & CSO sold 15,000 shares at an average $19.63 ($294,414)
- 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $19.63 ($294,414)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $19.63 ($392,519)
- 4 Open-market sale President & CSO sold 20,000 shares at an average $19.63 ($392,519)
- 4 Exercise or conversion Director acquired 3,030 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President & CSO sold 20,000 shares at an average $22.37 ($447,381)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $22.37 ($447,381)
- 4 Derivatives Options or other derivatives
Page 15 of 31 · 601 filings